Rehabilitation demand is piling up faster than the equipment can reach people. That is the uncomfortable fact sitting beneath Wissen Research's forecast for a global rehabilitation equipment market rising from $19.1 billion in 2026 to $25.8 billion by 2031, a 6.2% annual growth rate. It is a respectable expansion story, not some rocket-ship fairy tale. More important, it is rooted in a real and growing need for mobility, recovery, independence, and daily support.
Need Is Massive, Access Is Still Miserable
The World Health Organization estimated in February 2025 that roughly 2.6 billion people have health conditions that could benefit from rehabilitation. More than 2.5 billion people need at least one assistive product, with that demand expected to top 3.5 billion by 2050. Those are staggering figures, and they explain why this category has durable legs.
But demand is not revenue until somebody can obtain, operate, maintain, and pay for the equipment. In some settings, assistive-product availability reaches only 3% of estimated need. Many low- and middle-income markets have fewer than 10 skilled rehabilitation practitioners per million people. More than half of people needing rehabilitation go without it in some countries. That is not a small logistical wrinkle; it is the central constraint on this entire market.
Investors watching the sector should resist the lazy conclusion that a giant unmet need automatically translates into easy sales. It does not. A powered wheelchair or robotic system can be clinically useful and still be out of reach because the local provider lacks trained staff, the patient cannot cover the out-of-pocket cost, or the reimbursement process is a bureaucratic mud pit.
Wheelchairs Are Becoming a Serious Competitive Battleground
Three of the four recent company announcements highlighted in the report involved wheelchairs. That tells the story better than any glossy market diagram. Mobility is where personalization, portability, electronics, seating, safety, and reimbursement all crash into one another.
Sunrise Medical introduced the QUICKIE QS7 R on November 9, 2026, pairing an ultra-light rigid frame with a compact FrontFold mechanism and configurable seating. Permobil launched its M4 Nexa on September 23, 2026, packing powered positioning features into a compact mid-wheel-drive chair and adding remote diagnostics and battery monitoring through Permobil Connect. Invacare's DHCare business introduced the AVIVA RX10 on September 1, with a narrow wheelbase, adjustable seating components, and LiNX driving control.
None of that is fluff. Users need equipment fitted to their bodies, homes, transportation realities, and level of independence. Still, customization cuts both ways. It can defend margins and make products genuinely better, but it complicates manufacturing, service, inventory, and coverage decisions. The company that promises tailored mobility but cannot service it reliably will lose trust fast.
Consolidation Signals That Scale Matters
Deals are clustering around specialized capabilities. DHCare proposed acquiring Ottobock's Human Mobility business in June 2026. Sunrise Medical bought Spinergy in November 2026 after acquiring Made for Movement in July 2025. Wandercraft acquired Ekso Bionics in October 2026, bringing robotic exoskeleton and advanced mobility know-how under one roof.
This makes sense. Distribution relationships, clinical credibility, service networks, regulatory know-how, and component expertise are hard to build from scratch. Jin Medical International's planned annual capacity of 200,000 electric wheelchairs and senior mobility scooters in Chuzhou is another reminder that manufacturing scale is arriving from China. Established suppliers cannot simply sit on premium brands and assume the gate is locked.
Connected Therapy Has Promise, Not a Blank Check
Robotics, sensors, virtual rehabilitation, AI-enabled therapy devices, and gamified tools are moving further beyond specialized clinics. Ekso Bionics' FDA-cleared EksoNR supports gait training for rehabilitation applications involving stroke, acquired brain injury, multiple sclerosis, and spinal cord injury. Its EksoPulse platform records measures such as walking time, distance, and speed for clinician review.
That data layer matters because therapy outside the clinic is becoming more important. Compact home equipment and tele-rehabilitation can make continuity of care less dependent on repeated travel. Yet connected gear needs a practical business case. Providers will ask whether it improves outcomes, saves clinician time, supports documentation, or eases reimbursement. Fancy sensors without a workflow benefit are just expensive ornaments.
Growth in rehabilitation equipment will be decided as much by delivery and support as by the device itself.
Policy Helps, but Payment Still Sets the Pace
WHO's Rehabilitation 2030 initiative and its more recent primary-care guidance point toward broader integration of rehabilitation into community and primary-care settings. That should support demand for adaptable, affordable equipment in homes, local centers, and outpatient facilities. North America remained the largest regional market in 2025, backed by established hospital networks and reimbursement structures, while Asia-Pacific is identified as the fastest-growing region.
Still, Medicare requirements for power mobility devices illustrate the recurring snag: practitioner evaluations, written orders, and evidence of qualifying mobility limitations. Documentation exists for valid reasons, but it adds friction for patients, suppliers, and clinicians. Elsewhere, weak funding and thin rehabilitation infrastructure can choke adoption before a product ever gets evaluated.
The sober read is encouraging but demanding. Therapy equipment leads the product market, physical rehabilitation and training lead applications, and home-based care is a real opportunity. The winners will not merely build clever machines. They will make durable, usable equipment that fits budgets, earns clinical confidence, and comes with the training and service needed to keep it working where people actually live.